Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 7:39 pm Sale | 2025-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | ADAR1 Capital Management LLC | 2,962 0.100% | -119,862 (-97.59%) | Filing History |
| 2025-08-14 6:12 pm Purchase | 2025-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 51,391 1.600% | 51,391 (New Position) | Filing History |
| 2025-08-14 4:39 pm Purchase | 2025-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | Nantahala Capital Management LLC | 1,109 0.060% | 1,109 (New Position) | Filing History |
| 2025-08-08 4:05 pm Purchase | 2025-07-02 | 13G | Cellectar Biosciences, Inc. CLRB | Hexstone Capital LLC | 150,000 5.600% | 150,000 (New Position) | Filing History |
| 2025-07-08 5:02 pm Purchase | 2025-07-01 | 13G | Cellectar Biosciences, Inc. CLRB | Mitchell P. Kopin | 140,101 4.990% | 140,101 (New Position) | Filing History |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Nantahala Capital Management LLC | 83,571 5.730% | -39,020 (-31.83%) | Filing History |
| 2025-02-13 3:49 pm Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 131,849 8.800% | -14,483 (-9.90%) | Filing History |
| 2025-02-03 4:57 pm Purchase | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 249,092 9.900% | 16,744 (+7.21%) | Filing History |
| 2025-01-27 10:07 am Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 67,407 4.900% | -21,337 (-24.04%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB | Nantahala Capital Management LLC | 122,591 9.990% | 14,928 (+13.87%) | Filing History |
| 2024-11-14 4:47 pm Purchase | 2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB | ADAR1 Capital Management LLC | 122,824 8.510% | 122,824 (New Position) | Filing History |
| 2024-11-14 1:26 pm Purchase | 2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 146,332 9.990% | 36,993 (+33.83%) | Filing History |
| 2024-08-14 7:15 pm Purchase | 2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 232,348 9.900% | 99,261 (+74.58%) | Filing History |
| 2024-07-11 5:37 pm Unchanged | 2024-06-28 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 133,086 9.900% | 0 (Unchanged) | Filing History |
| 2024-04-25 8:01 pm Sale | 2024-03-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 133,086 9.900% | -89,478 (-40.20%) | Filing History |
| 2024-02-14 8:31 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 222,564 9.900% | 150,622 (+209.36%) | Filing History |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Nantahala Capital Management LLC | 107,663 9.900% | 107,663 (New Position) | Filing History |
| 2024-02-14 4:29 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Lincoln Park Capital Fund LLC | 43,568 9.676% | 12,315 (+39.41%) | Filing History |
| 2024-02-14 3:23 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 109,339 9.990% | 46,504 (+74.01%) | Filing History |
| 2024-02-07 6:58 pm Purchase | 2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 88,744 8.700% | 24,903 (+39.01%) | Filing History |